Enzalutamide in Metastatic Prostate Cancer. Reply

Ian D. Davis; Martin R. Stockler; Christopher J. Sweeney

doi:10.1056/NEJMc1910553

Enzalutamide in Metastatic Prostate Cancer. Reply

Ian D. Davis, Martin R. Stockler, Christopher J. Sweeney

Eastern Health Clinical School Research

Research output: Contribution to journal › Letter › Other › peer-review

3 Citations (Scopus)

Original language	English
Pages (from-to)	1494-1495
Number of pages	2
Journal	The New England Journal of Medicine
Volume	381
Issue number	15
DOIs	https://doi.org/10.1056/NEJMc1910553
Publication status	Published - 10 Oct 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1056/NEJMc1910553

Cite this

@article{fcbb688e61a8432fbe2f237d57c6d1f4,

title = "Enzalutamide in Metastatic Prostate Cancer. Reply",

author = "Davis, {Ian D.} and Stockler, {Martin R.} and Sweeney, {Christopher J.}",

year = "2019",

month = oct,

day = "10",

doi = "10.1056/NEJMc1910553",

language = "English",

volume = "381",

pages = "1494--1495",

journal = "The New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachusetts Medical Society",

number = "15",

}

TY - JOUR

T1 - Enzalutamide in Metastatic Prostate Cancer. Reply

AU - Davis, Ian D.

AU - Stockler, Martin R.

AU - Sweeney, Christopher J.

PY - 2019/10/10

Y1 - 2019/10/10

UR - http://www.scopus.com/inward/record.url?scp=85073108607&partnerID=8YFLogxK

U2 - 10.1056/NEJMc1910553

DO - 10.1056/NEJMc1910553

M3 - Letter

C2 - 31597033

SN - 0028-4793

VL - 381

SP - 1494

EP - 1495

JO - The New England Journal of Medicine

JF - The New England Journal of Medicine

IS - 15

ER -

Enzalutamide in Metastatic Prostate Cancer. Reply

UN SDGs

Access to Document

Other files and links

Cite this